Search Results

Featured Topics

Toggle

Showing 25 of 1516 results

Teva Announces FDA Approval of QNASL Beclomethasone Dipropionate Nasal Aerosol for Treatment of Children with Seasonal and Perennial Allergic Rhinitis

Teva to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference

Teva to Present at the 33rd Annual J P Morgan Healthcare Conference

Teva to Report Fourth Quarter 2014 Financial Results on February 5 2015

Teva Receives FDA Approval for First Generic Nexium  Delayed Release Capsules in the United States

Teva Thanks Dr Phillip Frost for Board Service

Teva Files 2014 Annual Report on Form 20 F

Teva Bolsters Injectable Portfolio with Launch of Generic Lovenox and Generic Zyvox in the United States

Teva Announces FDA Acceptance for Review of NDA for its Investigational Twice Daily Hydrocodone Bitartrate Extended Release Tablets with Proprietary Abuse Deterrence Technology

Teva Announces Early Results of Debt Tender Offer Pricing Election of Early Settlement and Increase in Maximum Amount and Priority 2 Notes Tender Cap

Teva to Present at the Barclays Global Healthcare Conference

Teva Reinforces Leadership Position in CNS with Acquisition of Auspex

Global HOPE Teva and Direct Relief Partner to Bring Medicines to Help Improve the Lives of Children with Cancer in Africa

  1. Home
  2. News and Media
  3. Latest News

Teva and Eagle Pharmaceuticals Announce NDA for Bendamustine Rapid Infusion Product Accepted for Filing

Teva to Report First Quarter 2015 Financial Results on April 30 2015

Teva Files for Hart Scott Rodino Notification Regarding Proposed Acquisition of Mylan

Teva Presents Data Comparing Early Treatment with COPAXONE 40 mg mL to Delayed Start Treatment at 67th American Academy of Neurology AAN Annual Meeting in Washington D C

Teva to Report First Quarter 2014 Financial Results on May 1 2014

Teva Announces First Approval and Launch of Generic Lovaza Capsules in the United States

Teva Announces Launch of Generic Lunesta Tablets in the United States

Teva Settles Patent Litigation with Pfizer on Celebrex

Teva Announces Supreme Court Denial of Request for Interim Relief to Stay Court of Appeals Ruling for COPAXONE Patent Due to the Potential for the Company to Recover Patent Infringement Damages

Teva Issues Updated Conference Call Information for First Quarter 2014 Financial Results on May 1 2014

Teva Shares New Data on MS Therapies at 66th American Academy of Neurology AAN Annual Meeting

FDA Approves Teva s SYNRIBO Omacetaxine Mepesuccinate for Injection for Home Administration